Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

AMD Stock Drops 45%, But Analyst Sees Big Upside in 2025

Daniel Kim Views  

Advanced Micro Devices (AMD) / AMD
Advanced Micro Devices (AMD) / AMD

AMD stock fell sharply in early trading, extending its decline in the year’s second half.

The chipmaker’s shares have dropped about 45% since hitting an all-time high last spring, erasing approximately $140 billion in market value.

Despite the downturn, one Wall Street analyst sees significantly more upside potential than downside risk as we approach 2025.

On Monday, Northland analyst Gus Richard named AMD one of his top picks for 2025. He reiterated a $175 price target and highlighted the potential for even more significant gains.

Richard pointed out AMD’s AI strategy, powered by its product roadmap and total cost of ownership advantages.

He noted that the company’s server and client CPU offerings consistently outperform its competitors.

As challenges in the embedded and gaming sectors subside, Richard expects AMD to continue growing its market share in AI GPUs, server CPUs, and PC clients.

He projects AMD’s AI revenue to soar 83% year-over-year, reaching approximately $9.5 billion by 2025.

Moreover, in AMD’s data center segment, Richard forecasts a 26% growth in non-AI revenue to reach $7.7 billion, with further market share gains on the horizon.

He asserts that AMD’s Torino chip outperforms Intel Corporation’s Granite Rapids in most workloads.

Furthermore, Richard believes AMD will gain market share from Intel in the personal computer sector—an area he considers undervalued in AMD’s AI-focused investment thesis.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Honda's NSX Returns: A 1,000-Horsepower Electric Rival to Lexus LFR
  • Honda’s S7 Electric SUV: A Major Player in the Race for EV Dominance
  • Lamborghini's First EV: A 2,000-Horsepower Beast Built for Speed and Emotion
  • Ford Revives Classic Design with the 2025 Bronco Heritage Edition
  • ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible
  • Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE